Cybrexa Therapeutics’ Preclinical Data Demonstrate its alphalex™ Platform Enables Tumor Targeting of Multiple PARP Inhibitors, Effectively Inducing Significant Tumor Cell Killing When Combined with Chemotherapy

World News: . []

NEW HAVEN Conn May 15 2019 GLOBE NEWSWIRE -- Cybrexa Therapeutics a biotechnology LINK  developing a new class of cancer therapeutics through its LINK  tumor targeting platform today LINK  preclinical data supporting the potent ial of ...

More news and information about Cybrexa Therapeutics

Published By:

Globe Newswire: 22:01 GMT Wednesday 15th May 2019

Published: .

Search for other references to "cybrexa" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us